The Long View cover image

Dave Sekera: A Market Outlook for 2025 and Beyond

The Long View

INSIGHT

Healthcare Sector Valuation

  • Eli Lilly's high valuation skews the overall healthcare sector valuation upwards.
  • Removing Eli Lilly reveals the healthcare sector may be undervalued by 7-8%.
  • Medical devices, like Medtronic and Zimmer, are particularly attractive within healthcare.
00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner